ImpriMed
ImpriMed is a company that creates individualized drug response prediction technology to help veterinarians fight lymphoma. The company's technology provides precision medicine techniques that allow veterinary oncologists to find appropriate anticancer drugs by developing a patient-derived database for pet cancer treatment that can eventuallybe translated into human cancer care, allowing doctors to decide on a final treatment regimen based on a data-driven prediction of response success in each individual patient's body.
Biotechnology Medical Veterinary
Funding Amount: $23M
Funding Type: Series A
Funding Date: 2023-12-19
City & State: Mountain View, California
Country United States
Employee Count: 33
Similar Startups
Synthpop
Synthpop is streamlining healthcare, one workflow at a time. Synthpop’s AI agents perform complex healthcare administrative tasks - from fax wrangling and referral processing, to quickly validating medical orders against payor and clinical guidelines.
Jogo Health
Jogo Health comprises an AI driven mobile app and wearable sensors to to treat chronic pain, migraine, stroke, pelvic floor and movement disorders using the foundational science of EMG Biofeedback.
Marigold Health
Marigold Health uses AI-augmented chat support groups to reach and retain patients with behavioral health needs in community-based treatment. Patients receive a personalized wraparound support while care teams see dramatic gains in capacity using patients to engage each other.
Omniscent
Omniscent create enterprise grade clinical and research solutions applicable to a variety of brain-related disorders, including depression, chronic pain, cancer, bi-polar disorder, Alzheimer’s, dementia, and PTSD, with the goal of bringing predictive analytics to the world faster.